The importance of routine health check-ups cannot be overstated, particularly in the rapidly changing Indian healthcare environment. Regular health check-ups are crucial for preventive healthcare, supported by robust scientific evidence from across the world. Numerous studies highlight the benefits of routine screenings and examinations in promoting overall well-being. For instance, a study published in the Journal of General Internal Medicine emphasizes that regular check-ups lead to early detection of health issues, improving treatment outcomes. Early intervention has been linked to better survival rates in diseases such as cancer and cardiovascular conditions (JAMA Network Open). Regular health check-ups are particularly relevant to people in India due to the unique healthcare challenges and conditions prevalent in the country. India faces a dual burden of infectious diseases and a rapidly rising incidence of non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, and respiratory illnesses.
India Disease Caseload – In Brief The contribution of most major non-communicable disease groups to the total disease burden has increased all over India since 1990, including cardiovascular diseases, diabetes, chronic respiratory diseases, mental health and neurological disorders, cancers, musculoskeletal disorders, and chronic kidney disease. According to the study report “India: Health of the Nation’s States”- The India State-Level Disease Burden Initiative in 2017 by the Indian Council of Medical Research (ICMR), it is estimated that the proportion of deaths due to Non-Communicable Diseases (NCDs) in India has increased from 37.9% in 1990 to 61.8% in 2016. The four major NCDs are cardiovascular diseases (CVDs), cancers, chronic respiratory diseases (CRDs), and diabetes. Non-communicable diseases led to 66% of deaths in India in 2019, as per the WHO report. Among the leading non-communicable diseases, the largest disease burden or rate increase from 1990 to 2016 was observed for diabetes, at 80%, and ischaemic heart disease, at 34%.